The March issue of highlights new clinical science and reviews, including the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) on gastric retention before endoscopy, resumption of direct oral anticoagulants after colorectal submucosal dissection, and the utility of inpatient GI consults to clear patients for transesophageal echocardiogram. This month we also published articles on colorectal cancer, cirrhosis, eosinophilic esophagitis, pediatrics, irritable bowel syndrome, and more.
Several articles are highlighted below and access to any articles from this issue, or past issues, is available upon request. The College is also able to connect members of the press with study authors or outside experts who can comment on the articles.
Phan, et al.
This study examined patients taking GLP-1 RAs receiving an endoscopy to evaluate the effect of GLP-1 RAs on gastric retention. They found that only 8.7% of patients on GLP-1 RAs retained gastric contents after fasting for at least eight hours. There was no difference of proportions of GLP-1 RA types, duration on medications, or duration on current dosage of medications, and of those who had retained food, 93% had type 2 diabetes.
Ichita, et al.
A retrospective cohort study in Japan examined the resumption timing of direct oral anticoagulants (DOACs) after colorectal submucosal dissection. Patients were divided into two groups, early resumption (the day after ESD) and delayed resumption (203 days after ESD), and they found that early resumption of DOACs was associated with reduced thromboembolic events without significant increase in risk of delayed bleeding.
Mizrahi, et al.
A prospective cohort study of 732 inpatients who had a transesophageal echocardiogram (TEE) assessed the clinical utility of inpatient GI services called to clear patients for the procedure when they have GI symptoms or comorbidities. The authors found that inpatient GI team workups to clear patients for a TEE found no contraindications to TEEs, did not change patient care plans, and led to increased hospital costs and lengths of stay.
About the American College of Gastroenterology
Founded in 1932, the American College of Gastroenterology (ACG) is an organization with an international membership of over 19,000 individuals from 86 countries. The College's vision is to be the preeminent organization supporting health care professionals who provide compassionate, equitable, high-quality, state-of-the-art, and personalized care to promote digestive health. The mission of the College is to provide tools, services, and accelerate advances in patient care, education, research, advocacy, practice management, professional development and clinician wellness, enabling our members to improve patients’ digestive health and to build personally fulfilling careers that foster well-being, meaning and purpose. Learn more at .